Contribution: Industrial Research Assistance Program – Contributions to Firms
Hexiris Inc.
$75,000.00
Verification on MIGS
FY 2024-25 · 2024-06-03
Summary
Complete prototype validation of innovative MIGS (Minimally Invasive Glaucoma Surgery) devices which will enable bringing glaucoma surgery from the operating room to outpatient clinics. By the end of October 2024, Hexiris will have conducted successful testing of the Functional MIGS on both animal and human cadaveric eyes, demonstrating its efficacy and safety for progression to animal and human clinical trials.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Dieppe|Dieppe, New Brunswick, Canada
Recipient Type
For-profit organization
Business Number
766125470
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-06-03 | 2024-25 | $75,000.00 |
| 1 | 2024-06-03 | 2024-25 | $75,000.00 |
| 2 | 2024-06-03 | 2024-25 | $75,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 90 jours.
Agreement End Date
2025-03-31
Agreement Number
1019421
Agreement Start Date
2024-06-03
Agreement Title
Verification on MIGS
Agreement Title (French)
Vérification sur les MIGS
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2025-01-06
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Complete prototype validation of innovative MIGS (Minimally Invasive Glaucoma Surgery) devices which will enable bringing glaucoma surgery from the operating room to outpatient clinics. By the end of October 2024, Hexiris will have conducted successful testing of the Functional MIGS on both animal and human cadaveric eyes, demonstrating its efficacy and safety for progression to animal and human clinical trials.
Description (French)
Achever la validation du prototype des dispositifs innovants MIGS (Minimally Invasive Glaucoma Surgery) qui permettront de faire passer la chirurgie du glaucome de la salle d’opération aux cliniques ambulatoires. D’ici la fin du mois d’octobre 2024, Hexiris aura mené avec succès des essais du MIGS fonctionnel sur des yeux cadavériques d’animaux et d’humains, démontrant ainsi son efficacité et son innocuité en vue d’une progression vers des essais cliniques chez l’animal et l’humain.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Beauséjour
Federal Riding (French)
Beauséjour
Federal Riding Number
13002
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
766125470
Recipient City
Dieppe|Dieppe
Recipient Country
CA
Recipient Legal Name
Hexiris Inc.
Recipient Operating Name
Hexiris
Recipient Postal Code
E1A 9T8
Recipient Province or Territory
NB
Recipient Type
F
Reference Number
172-2024-2025-Q1-1019421
